Interestingly, there are reports that plasma levels of NF-L protein appear to be increased in AD and may be used as a reliable diagnostic marker for AD incidence and severity (Lista et al., 2017; Abu-Rumeileh et al., 2018; Hampel et al., 2018). Here, NEFL is linked to Alzheimer disease.